NCT00265798 2026-04-28Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib MalateNational Cancer Institute (NCI)Phase 2 Active not recruiting38 enrolled 9 charts